Salix Boulet Selected Research

Contraindications

1/2009

Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salix Boulet Research Topics

Disease

8	Infections 01/2012 - 03/2008
3	Disease Progression 11/2014 - 07/2007
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2011 - 07/2008
3	HIV Infections (HIV Infection) 01/2009 - 07/2008
1	Obesity 01/2018
1	Weight Gain 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Neoplasms (Cancer) 11/2016
1	Pathologic Neovascularization 11/2014
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2014
1	Viremia 07/2007

Drug/Important Bio-Agent (IBA)

3	HLA-B57 antigenIBA 06/2011 - 07/2008
3	LigandsIBA 06/2011 - 02/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 11/2014
2	Peptides (Polypeptides)IBA 04/2010 - 07/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Neuropilin-1IBA 01/2018
1	Semaphorin-3AIBA 11/2014
1	Oxygen (Dioxygen)IBA 11/2014
1	AntigensIBA 01/2012
1	CytokinesIBA 01/2012
1	ProteomeIBA 04/2010
1	HLA-Bw4 antigenIBA 02/2010
1	Interleukin-2 (IL2)IBA 05/2009
1	HLA-B Antigens (HLA-B)IBA 07/2008
1	Natural Killer Cell ReceptorsIBA 07/2008
1	KIR ReceptorsIBA 03/2008

Therapy/Procedure

1	Highly Active Antiretroviral Therapy (HAART) 01/2009
1	Contraindications 01/2009